FDA & Healthcare Upcoming Events

Related Events

02/29/12-03/02/12 2012 IMS Managed Markets Services/DataNiche Conference Las Vegas, NV

Donna Lee Yesner, speaker

03/29/12-03/31/12 National Hospice and Palliative Care Organization (NHPCO) 27th Management and Leadership Conference National Harbor, MD

Howard Young, panelist, "The OIG and Hospice in Nursing Facilities: Past, Present and Future"

04/29/12 HCCA's 16th Annual Compliance Institute

Howard Young, speaker, "Handling a Health Care Fraud Investigation"

View all events

Related Publications

02/09/12 FDA Issues Three Draft Guidances for Biosimilars

Initial guidance provides insights on regulatory pathway for biosimilars, but does not address many critical issues.

02/06/12 CMS Proposes Major Changes to AMP Rule

The Proposed Rule provides provisions that will significantly impact pharmaceutical manufacturers' rebate liability, price reporting calculations, and possibly their operations.

01/26/12 Transparency Compliance Webinar

View all publications

Related News

09/06/11 Former FDA Regulatory Counsel Returns to Morgan Lewis

Morgan Lewis announces that Alexis Reisin Miller has returned to the firm as a partner in its FDA & Healthcare Practice, resident in Washington, D.C.

07/13/11 Morgan Lewis Team Advises Kinetic Concepts on Company’s $6.3 Billion Acquisition by Apax

Morgan Lewis advised Kinetic Concepts, Inc. (KCI), on a definitive merger agreement under which a consortium comprised of private equity funds will acquire KCI in a $6.3 billion transaction.

05/11/11 Morgan Lewis Further Expands FDA & Healthcare Practice with Government Healthcare Contracts Duo

Morgan Lewis announces that Donna Lee Yesner and Stephen E. Ruscus have joined the firm as partners in its FDA and Healthcare practice, resident in Washington.

View all news

Fast Facts

^PLCCross-border Quarterly 2009 Life Sciences Legal Market Review

Industry Super League - Ranked 16th among law firms worldwide
Regulatory Super League - Ranked 7th among law firms worldwide

^PLCCross-border Life Sciences Handbook 2007/2008

U.S. - Recognized for commercial/ partnering, competition/ antitrust, corporate, government law enforcement/ investigations, regulatory, regulatory/ medical devices, and patent counseling
England - Recognized for regulatory
Japan - Recognized for corporate/commercial

Chambers USA 2011: Washington, D.C. for healthcare/ pharmaceutical/medical products regulatory – Band 3

UK Legal 500 2007/2008: London: Pharmaceuticals and Biotechnology

Areas of Experience

Related Practices

Title	Event Type	Start Date	End Date
2012 IMS Managed Markets Services/DataNiche Conference Donna Lee Yesner, speaker	Conferences and Speeches	02/29/2012	03/02/2012
National Hospice and Palliative Care Organization (NHPCO) 27th Management and Leadership Conference Howard Young, panelist, "The OIG and Hospice in Nursing Facilities: Past, Present and Future"	Conferences and Speeches	03/29/2012	03/31/2012
HCCA's 16th Annual Compliance Institute Howard Young, speaker, "Handling a Health Care Fraud Investigation"	Conferences and Speeches	04/29/2012 01:30 PM	04/29/2012 04:30 PM
ABA's National Institute on Internal Corporate Investigations and Forum for In-House Counsel 2012 Arianne Callender, panelist, "The Responsible Corporate Officers Doctrine: New and Evolving Threats Facing In-House Counsel"	Conferences and Speeches	05/17/2012 09:45 AM	05/17/2012
2012 Health Law Institute in Minneapolis Arianne Callender, speaker, "Fraud and Abuse Update"	Conferences and Speeches	06/06/2012	06/07/2012

FDA & Healthcare Upcoming Events

For More Information

Read the Brochure

FDA Food Safety Modernization Act

Resources